FR2313029A1 - Fluoroprostaglandines, procede permettant leur preparation, et leur utilisation therapeutique - Google Patents

Fluoroprostaglandines, procede permettant leur preparation, et leur utilisation therapeutique

Info

Publication number
FR2313029A1
FR2313029A1 FR7608070A FR7608070A FR2313029A1 FR 2313029 A1 FR2313029 A1 FR 2313029A1 FR 7608070 A FR7608070 A FR 7608070A FR 7608070 A FR7608070 A FR 7608070A FR 2313029 A1 FR2313029 A1 FR 2313029A1
Authority
FR
France
Prior art keywords
fluoroprostaglandins
preparation
therapeutic use
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7608070A
Other languages
English (en)
French (fr)
Other versions
FR2313029B1 (US20050065096A1-20050324-C00039.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT21493/75A external-priority patent/IT1049373B/it
Application filed by Carlo Erba SpA filed Critical Carlo Erba SpA
Publication of FR2313029A1 publication Critical patent/FR2313029A1/fr
Application granted granted Critical
Publication of FR2313029B1 publication Critical patent/FR2313029B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7608070A 1975-03-21 1976-03-19 Fluoroprostaglandines, procede permettant leur preparation, et leur utilisation therapeutique Granted FR2313029A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT149375 1975-03-21
IT21493/75A IT1049373B (it) 1975-03-21 1975-03-21 Fluoro prostaglandine

Publications (2)

Publication Number Publication Date
FR2313029A1 true FR2313029A1 (fr) 1976-12-31
FR2313029B1 FR2313029B1 (US20050065096A1-20050324-C00039.png) 1979-09-21

Family

ID=26325130

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7608070A Granted FR2313029A1 (fr) 1975-03-21 1976-03-19 Fluoroprostaglandines, procede permettant leur preparation, et leur utilisation therapeutique

Country Status (10)

Country Link
US (4) US4338332A (US20050065096A1-20050324-C00039.png)
AT (1) AT351189B (US20050065096A1-20050324-C00039.png)
AU (1) AU501803B2 (US20050065096A1-20050324-C00039.png)
BE (1) BE839789A (US20050065096A1-20050324-C00039.png)
CA (1) CA1103663A (US20050065096A1-20050324-C00039.png)
CH (2) CH629769A5 (US20050065096A1-20050324-C00039.png)
DE (1) DE2611788C2 (US20050065096A1-20050324-C00039.png)
FR (1) FR2313029A1 (US20050065096A1-20050324-C00039.png)
GB (1) GB1493557A (US20050065096A1-20050324-C00039.png)
NL (1) NL7602862A (US20050065096A1-20050324-C00039.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368473A1 (fr) * 1976-06-01 1978-05-19 Erba Carlo Spa O-nor-aromatique-13,14-dehydro-prostaglandines, leur procede de preparation et leur utilisation comme contraceptifs
FR2551436A1 (fr) * 1983-09-07 1985-03-08 Erba Farmitalia 16-fluoro-16,17-dideshydro-prostanoides, procede pour leur preparation, produits intermediaires de leur preparation et leurs utilisations therapeutiques, notamment dans les indications des prostaglandines naturelles

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3004795A1 (de) * 1980-02-07 1981-08-13 Schering Ag Berlin Und Bergkamen, 1000 Berlin Neue prostacyclinderivate, ihre herstellung und anwendung
SU1256394A1 (ru) * 1984-04-24 1987-06-07 Институт Органического Синтеза Ан Латвсср Производные 15( @ + @ )-фтор-11,15-дидезоксипростагландина @ ,обладающие антиагрегационной активностью
ES2099822T3 (es) * 1991-04-22 1997-06-01 Taisho Pharmaceutical Co Ltd Analogo de prostaglandina e1.
ATE202557T1 (de) * 1996-11-12 2001-07-15 Alcon Lab Inc 15-fluoro-prostaglandine als augendrucksenkende mittel

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959346A (en) * 1969-03-14 1976-05-25 The Upjohn Company Racemic prostaglandins of the 2-series and analogs thereof
GB1425962A (en) * 1972-04-13 1976-02-25 Erba Carlo Spa Lactols and lactones
DE2317019A1 (de) * 1972-04-27 1973-11-08 Upjohn Co Neue 4,5-didehydro-prostaglandine
US3862979A (en) * 1972-06-15 1975-01-28 Erba Carlo Spa 9-desoxy-prosta-5,9(10),13-trienoic acid derivatives
US3933899A (en) * 1972-10-30 1976-01-20 The Upjohn Company PGE2 -oxa-phenylene compounds
US3914282A (en) * 1973-01-16 1975-10-21 Upjohn Co Prostaglandin E{HD 1{B , F{HD 1{B , and A{HD 1 {B analogs
JPS5720305B2 (US20050065096A1-20050324-C00039.png) * 1973-02-28 1982-04-27
US3962293A (en) * 1973-07-20 1976-06-08 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin F1
US3932463A (en) * 1974-06-03 1976-01-13 American Cyanamid Company 11-Deoxy-13-dihydro-prostaglandin-9-ketals
IT1053781B (it) * 1974-09-25 1981-10-10 Erba C S P A Ora Farmitalia Omega nor cicloalcil 13.14 deidro prostaglandine
IT1037126B (it) * 1975-03-14 1979-11-10 Erba Carlo Spa 13.4 deidro ii desossi prosta glandine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368473A1 (fr) * 1976-06-01 1978-05-19 Erba Carlo Spa O-nor-aromatique-13,14-dehydro-prostaglandines, leur procede de preparation et leur utilisation comme contraceptifs
FR2551436A1 (fr) * 1983-09-07 1985-03-08 Erba Farmitalia 16-fluoro-16,17-dideshydro-prostanoides, procede pour leur preparation, produits intermediaires de leur preparation et leurs utilisations therapeutiques, notamment dans les indications des prostaglandines naturelles

Also Published As

Publication number Publication date
US4338332A (en) 1982-07-06
US4320143A (en) 1982-03-16
BE839789A (fr) 1976-07-16
CH623570A5 (US20050065096A1-20050324-C00039.png) 1981-06-15
FR2313029B1 (US20050065096A1-20050324-C00039.png) 1979-09-21
US4229585A (en) 1980-10-21
US4338249A (en) 1982-07-06
AT351189B (de) 1979-07-10
CA1103663A (en) 1981-06-23
DE2611788A1 (de) 1976-09-30
AU1191776A (en) 1977-09-15
CH629769A5 (de) 1982-05-14
DE2611788C2 (de) 1986-03-27
AU501803B2 (en) 1979-06-28
GB1493557A (en) 1977-11-30
ATA204576A (de) 1978-12-15
NL7602862A (nl) 1976-09-23

Similar Documents

Publication Publication Date Title
LU80081A1 (fr) Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
LU76848A1 (fr) Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application therapeutique
BE845551A (fr) Acides heteroarylbenzoxepine-acetiques, leur procede de preparation et leur application
BE847090A (fr) 15-steroides, et leur procede de preparation
BE827323A (fr) Nouvelles diaryl-1,1 oxadiazole-1 alkylamines, leur procede de preparation et leur utilisation therapeutique
BE846452A (fr) Nouvelles pyrimidones, leur procede de preparation et leur applicationtherapeutique
FR2281124A1 (fr) Nouveaux steroides cardiotoniques, leur procede de preparation, et leur utilisation therapeutique
FR2301521A1 (fr) Nouvelles n-acyl-n-norsalutaridines et leur procede de preparation
FR2307530A1 (fr) Triaryl-1,1,1 alkylamines et leur procede de preparation
BE849504A (fr) Acides aminodi- et polyalkylamidoalcane sulfoniques, leur procede de preparation et leur utilisation
FR2351965A1 (fr) Benzenesulfonylurees, leur procede de preparation et leur application therapeutique
BE854133A (fr) 1,3-dihydro-heteroarylspito(isobenzofurannes)et leur procede de preparation et leur application therapeutique
FR2313029A1 (fr) Fluoroprostaglandines, procede permettant leur preparation, et leur utilisation therapeutique
FR2317298A1 (fr) Nouvelles lactones et leur procede de preparation
FR2299865A1 (fr) Arylmethyl-1 imidazolidones-2 et leur procede de preparation
FR2347370A1 (fr) 7-amino-3-tetrazolyl substitue-thiomethyl-cephalosporines et leur procede de preparation
BE849571A (fr) Diurethannes, leur procede de preparation et leur utilisation
BE848910A (fr) Nouveaux fluorures de carbamate-carbamoyle et leur procede de preparation,
BE860773A (fr) Beta-lactames monocycliques, leur procede de preparation et leur application en therapeutique
FR2333792A1 (fr) 4-hydroxymethyl-2-pyrrolidinones et leur procede de preparation
FR2330390A2 (fr) Nouvelles benzodioxanes-1,4, leur procede de preparation et leur application en therapeutique
BE860437A (fr) Diurethannes, leur procede de preparation et leur utilisation
LU80474A1 (fr) 4-desacetoxy-4alpha-hydroxyindole-dihydroindoles,leur procede de preparation et leur utilisation therapeutique
FR2313036A1 (fr) Nouvelles thienyl-prostaglandines, leur procede de preparation et leur application
BE847222A (fr) Tetrahydrominobenzo (b)) thien-4-ylyrees, leur procede de preparation et leur utilisation therapeutique

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse